2014

Researchers identify first blood biomarker for progressive kidney disease

July 2, 2014

FDA-approval required before clinical use

A new blood test has the potential to reveal whether a person recently diagnosed with type 1 diabetes is already at risk for kidney failure—information that might allow physicians to alter the course of treatment and slow disease progression.

This is the hope of Harvard Stem Cell Institute (HSCI) scientists at Brigham and Women’s Hospital who recently demonstrated that a laboratory test could detect, in the blood of mice and humans, the...

Read more about Researchers identify first blood biomarker for progressive kidney disease

JDRF RFA on developing and testing glucose-responsive insulin

June 6, 2014

LOI Deadline July 11

JDRF requests letters of intent for: Glucose responsive insulin discovery and validation

PURPOSE: JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Letters of Intent (LOI) for the discovery and validation of novel glucose responsive insulin (GRI) drugs for better treatment of insulin-dependent diabetes mellitus (IDDM) and reducing the burden of daily management of the disease, particularly T1D.
 
BACKGROUND: Since...

Read more about JDRF RFA on developing and testing glucose-responsive insulin

Pages